MedPath

Investigating red blood cells of sickle cell patients who started therapy.

Conditions
sickle cell anemiaHbSSHbSCSikkelcelziekte
Registration Number
NL-OMON24314
Lead Sponsor
niversity Medical Center Utrecht
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
Not specified
Target Recruitment
20
Inclusion Criteria

1.„h No blood transfusion within the past 2 months

2. Diagnosed with sickle cell anemia (HbSS, HbSC or HbS/beta-thal)

Exclusion Criteria

1. Blood transfusion within past 2 months

2. Body weight below 10 kg

Study & Design

Study Type
Observational non invasive
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Red blood cell deformability
Secondary Outcome Measures
NameTimeMethod
Changes in red blood cell deformability over time and correlations with other laboratory parameters and clinical symptoms and signs.
© Copyright 2025. All Rights Reserved by MedPath